scispace - formally typeset
K

Katarzyna Gucwa

Researcher at Gdańsk University of Technology

Publications -  12
Citations -  234

Katarzyna Gucwa is an academic researcher from Gdańsk University of Technology. The author has contributed to research in topics: Candida albicans & Candida glabrata. The author has an hindex of 5, co-authored 11 publications receiving 169 citations.

Papers
More filters
Journal ArticleDOI

Essential Oils, Silver Nanoparticles and Propolis as Alternative Agents Against Fluconazole Resistant Candida albicans, Candida glabrata and Candida krusei Clinical Isolates

TL;DR: Investigation of in vitro antifungal activity of selected essential oils, ethanolic extracts of propolis and silver nanoparticles dropped on TiO2 against azole-resistant C. albicans, C. glabrata and C. krusei revealed that constituents of most of essential oils and propolis are not substrates for drug transporters, which belong to the most important factors affecting resistance of Candida spp.
Journal ArticleDOI

Investigation of the Antifungal Activity and Mode of Action of Thymus vulgaris, Citrus limonum, Pelargonium graveolens, Cinnamomum cassia, Ocimum basilicum, and Eugenia caryophyllus Essential Oils.

TL;DR: All of the tested oils demonstrated the ability to inhibit the transition of yeast to mycelium form, but the effect was the lowest in the case of cinnamon oil, the highest activity was observed for cinnamon oil.
Journal ArticleDOI

Antifungal Activity and Synergism with Azoles of Polish Propolis

TL;DR: Evidence for the fungal cell membrane as the most probable target of EEPs are presented.
Journal ArticleDOI

Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland

TL;DR: The aim of the presented study was to determine the mechanisms of resistance to azoles in 81 C. glabrata clinical isolates from three different hospitals in Poland, and found that 18 strains were resistant to fluconazole, and 15 were cross-resistant to all other azoles tested.
Journal ArticleDOI

Peptide conjugates of lactoferricin analogues and antimicrobials-Design, chemical synthesis, and evaluation of antimicrobial activity and mammalian cytotoxicity

TL;DR: Eight new peptide conjugates composed of modified bovine lactoferricin truncated analogues (LFcinB) and one of the three antimicrobials - ciprofloxacin (CIP), levofloxac in LVX, and fluconazole (FLC) - were synthesized and showed activity against Gram-positive bacteria, especially S. epidermidis.